23rd American Pharma & Biotech Project, Program and Portfolio Conference

16–18 Oct 2024 | Boston, Massachusetts, United States

Alan Zulick

Director Program Management

ImmunoGen

Boston, United States

14 profile visitsSpeakerSpeaker

About me

My organisation

ImmunoGen

ImmunoGen is now part of AbbVie.

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.

Social media

Speaker sessions (1)

Friday, 18 October 2024

13:30 - 14:00

KEYNOTE: Optimizing strategic planning by connecting corporate goals to project plans

Format:In-personLocation:Beacon Hill Ballroom
  • Cell & Gene Therapy Resource Planning And New Modalities